Growth Metrics

Biomerica (BMRA) Gains from Investment Securities (2016 - 2026)

Biomerica's Gains from Investment Securities history spans 17 years, with the latest figure at $10471.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 97.49% to $10471.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $10471.0, a 97.49% decrease, with the full-year FY2025 number at $413866.0, up 1561.71% from a year prior.
  • Gains from Investment Securities hit $10471.0 in Q1 2026 for Biomerica, down from $444708.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for BMRA hit a ceiling of $3.5 million in Q1 2024 and a floor of -$323805.0 in Q2 2022.
  • Historically, Gains from Investment Securities has averaged $420340.5 across 5 years, with a median of $49000.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 386.43% in 2022 and later skyrocketed 227911.6% in 2023.
  • Tracing BMRA's Gains from Investment Securities over 5 years: stood at $1000.0 in 2022, then skyrocketed by 227911.6% to $2.3 million in 2023, then tumbled by 85.44% to $332000.0 in 2024, then skyrocketed by 33.95% to $444708.0 in 2025, then plummeted by 97.65% to $10471.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for BMRA at $10471.0 in Q1 2026, $444708.0 in Q4 2025, and $720.0 in Q3 2025.